Creon 12000 [USP'U]/1

Creon 12000 is a delayed-release pancreatic enzyme supplement used to aid digestion in individuals with exocrine pancreatic insufficiency. It contains pancrelipase to help break down fats, proteins, and carbohydrates. This medication is available in capsule form and is manufactured by AbbVie Inc.

Creon 12000 is primarily used to manage digestive issues related to exocrine pancreatic insufficiency. This condition occurs when the pancreas does not produce enough enzymes to digest food properly. The medication helps break down fats, proteins, and carbohydrates, making it easier for the body to absorb essential nutrients. People with conditions like cystic fibrosis or chronic pancreatitis may benefit from this enzyme supplement.

Common effects of Creon 12000 may include improved digestion and nutrient absorption. Some individuals might experience mild gastrointestinal discomfort, such as bloating or diarrhea, especially when starting the medication. These effects are generally temporary and should subside as the body adjusts to the enzyme supplement.

Creon 12000 should be taken as directed by a healthcare provider. It is important to swallow the capsules whole and not crush or chew them, as this can affect their delayed-release mechanism. Individuals with known allergies to pancreatic enzymes or any components of the medication should avoid using it. Always consult a healthcare provider before starting any new medication.

Creon 12000 may interact with certain medications, particularly those that affect the digestive system. It is advisable to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also impact the effectiveness of the medication, so it is best to follow a balanced diet and avoid excessive alcohol consumption.